Type 2 Diabetes

Youths diagnosed with type 2 diabetes at an older age and those who adhere to metformin therapy are more likely to progress to therapy with insulin or a non-insulin antihyperglycemic agent, according to a speaker.

There was a significant increase in the number of cases of new-onset type 2 diabetes among children during the first 9 months of the COVID-19 pandemic, especially among boys and Black youths, according to a speaker.

More than 70% of patients admitted to a hospital in Japan with moderate COVID-19 whose condition worsened during hospitalization had dysglycemia, according to study findings.

For Silvio E. Inzucchi, MD, a simple question from a patient who underwent coronary artery bypass graft surgery would spur an interest in clinical research that helped lead to paradigm changing discoveries.

The investigational glucose-dependent insulinotropic polypeptide/GLP-1 receptor agonist tirzepatide led to significant and superior HbA1c and body weight reductions for adults with type 2 diabetes vs. semaglutide, SURPASS-2 study data show.

Hospitalizations for new-onset type 2 diabetes in children increased during the COVID-19 pandemic in 2020 compared with the same period in 2019, according to findings presented at the American Diabetes Association Scientific Sessions.

Add-on proton pump inhibitor therapy improved glycemic markers among adults with type 2 diabetes, but did not alter risk for incident diabetes, according to a meta-analysis published in The Journal of Clinical Endocrinology & Metabolism.

The use of statins in patients with recently diagnosed type 2 diabetes reduced incidence of CVD and death, particularly in older and adherent patients, according to a study.

Family support is a crucial part of self-management for Black adults with type 2 diabetes and should be a focus in interventions, according to a qualitative study published in The Science of Diabetes Self-Management and Care.

Sotagliflozin increased the number of days alive and out of the hospital compared with placebo among patients with type 2 diabetes at high risk for intermittent hospitalization due to worsening heart failure, data show.